drugset

drugset / Trial / NCT01096966

Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain

NCT01096966 ↗

Phase 2 Completed 263 enrolled Durect Pfizer · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

This study will evaluate the efficacy and safety of Bupivacaine TTS (Bupivacaine patch) compared to placebo in patients with chronic low back pain.

Timeline

Start: 2010-03
Primary completion: 2011-02
Completion: 2011-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bupivacaine	Other / unclassified	—	Other

Indications